Creative Planning
TARS icon

Creative Planning’s Tarsus Pharmaceuticals TARS Stock Holding History

Creative Planning’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
14,392
+366
+3% +$25.6K ﹤0.01% 2446
2025
Q4 		$1.15M Buy
14,026
+1,659
+13% +$124K ﹤0.01% 2174
2025
Q3 		$735K Buy
12,367
+393
+3% +$19.3K ﹤0.01% 2397
2025
Q2 		$485K Sell
11,974
-2,329
-16% -$105K ﹤0.01% 2494
2025
Q1 		$735K Buy
14,303
+1,126
+9% +$55.7K ﹤0.01% 1972
2024
Q4 		$730K Buy
13,177
+2,175
+20% +$98.8K ﹤0.01% 1896
2024
Q3 		$362K Buy
+11,002
New +$309K ﹤0.01% 2371
2024
Q2 		– Sell
-6,595
Closed -$240K – 3168
2024
Q1 		$240K Buy
+6,595
New +$194K ﹤0.01% 2434

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Creative Planning's TARS Position: Q1 2026 in Review

Creative Planning increased its Tarsus Pharmaceuticals (TARS) stake by 2.6% in Q1 2026, buying an estimated $25.6K and bringing the position to 14,392 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2446.

Creative Planning first reported a position in TARS in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.15M in Q4 2025. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

  • Creative Planning held 14,392 shares of Tarsus Pharmaceuticals worth $1.01M as of Q1 2026.
  • Creative Planning bought 366 Tarsus Pharmaceuticals shares in Q1 2026, an estimated $25.6K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2446 holding.
  • Creative Planning first reported a position in Tarsus Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • Creative Planning's Tarsus Pharmaceuticals position peaked at $1.15M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.